Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, February 2004, p. 615-618, Vol. 48, No. 2
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.2.615-618.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
fexA, a Novel Staphylococcus lentus Gene Encoding Resistance to Florfenicol and Chloramphenicol
Corinna Kehrenberg and Stefan Schwarz*
Institut für Tierzucht, Bundesforschungsanstalt für Landwirtschaft, 31535 Neustadt-Mariensee, Germany
Received 23 April 2003/
Returned for modification 21 September 2003/
Accepted 19 October 2003

ABSTRACT
The
Staphylococcus lentus plasmid pSCFS2 carries a novel florfenicol-chloramphenicol
resistance gene, designated
fexA, encoding a protein of 475
amino acids with 14 transmembrane domains. The FexA protein
differs from all previously known proteins involved in the efflux
of chloramphenicol and florfenicol. Induction of
fexA expression
by chloramphenicol and florfenicol occurs via translational
attenuation.

INTRODUCTION
Florfenicol is a fluorinated derivative of chloramphenicol which
was licensed in Germany for the control of bacterial respiratory
tract infections in 1995 for cattle and in 2000 for swine. In
contrast to chloramphenicol, florfenicol is exclusively used
in veterinary medicine (
11), and the known chloramphenicol acetyltransferases
are unable to inactivate florfenicol (
6). While chloramphenicol
acetyltransferase genes (
cat genes) have been detected in a
wide variety of gram-positive bacteria, including staphylococci
of human and animal origin (
5,
16), only a single gene,
cfr,
from bovine
Staphylococcus sciuri, has been observed to mediate
combined resistance to florfenicol and chloramphenicol by a
yet-unknown mechanism (
13). The
cfr gene is located on the 17-kb
plasmid pSCFS1, which also confers resistance to macrolide-lincosamide-streptogramin
B antibiotics and spectinomycin (
12).
In this study, the bovine Staphylococcus lentus isolate no. 8, obtained from the nasal swab of a calf suffering from a respiratory tract infection, was shown to be resistant to chloramphenicol, clindamycin, erythromycin, florfenicol, streptomycin, and tetracycline by agar disk diffusion (7) and was shown to carry six plasmids of ca. 2 to 34 kb. After transformation into protoplasts of Staphylococcus aureus RN4220, a 34-kb plasmid, designated pSCFS2, mediated only resistance to florfenicol and chloramphenicol. MICs for S. aureus RN4220:pSCFS2 were 32 µg of florfenicol/ml and 64 µg of chloramphenicol/ml (Table 1) as determined by the microdilution broth method (7). Preincubation in the presence of either 0.5 µg of chloramphenicol/ml or 0.5 µg of florfenicol/ml led to a fourfold increase of both MICs (Table 1). Since PCR assays and hybridization experiments did not reveal the presence of the cfr gene, cloning experiments using BglII-digested pSCFS2 DNA and BamHI-digested vector pBluescript II SK(+) (Stratagene, Amsterdam, The Netherlands) were performed. After transformation into Escherichia coli JM109, only transformants that carried a 7-kb BglII insert grew on Luria-Bertani agar plates supplemented with 10 µg of florfenicol/ml. They exhibited MICs of 16 µg of florfenicol/ml and 64 µg of chloramphenicol/ml, which could be increased to 64 µg of florfenicol/ml and 128 µg of chloramphenicol/ml, respectively, by preincubation in the presence of either 0.5 µg of chloramphenicol/ml or 0.5 µg of florfenicol/ml (Table 1). These observations suggested that the resistance gene in question is expressed inducibly in gram-positive and gram-negative hosts and that both antimicrobial agents, florfenicol and chloramphenicol, are effective as inducers.
Within the 7-kb
BglII fragment, a single
EcoRI site was detected.
Subclones which carried
EcoRI/
BglII inserts of 5.2 and 1.8 kb
proved to be susceptible to florfenicol and chloramphenicol,
suggesting that this
EcoRI site is located either within the
gene in question or in its regulatory region. Sequence analysis
was performed on both strands by primer walking, starting at
the
EcoRI sites of both subclones and using the M13 universal
and reverse primers. The nucleotide sequence of a 1,674-bp fragment
of plasmid pSCFS2 was determined. Analysis of this region confirmed
the presence of two open reading frames (ORFs), one of them
coding for a protein of 475 amino acids (aa) (position 177 to
1604), the other coding for a small peptide of 9 aa (position
118 to 147) preceding the aforementioned ORF.
The reading frame for the 475-aa protein was designated fexA (for florfenicol exporter), and the EcoRI site was located within this reading frame at position 1334. Analysis of the fexA upstream region revealed striking homologies to the translational attenuators upstream of chloramphenicol-inducible staphylococcal cat genes (4) and also to that of the chloramphenicol-inducible gene cmlA from Tn1696 (14). In addition to the reading frame for the 9-aa peptide, a pair of inverted repeated sequences (IR1 and IR2) of 11 bp was detected. These inverted repeats might be able to form a stable mRNA stem-loop structure (
G = -74.4 kJ/mol) (15) with the fexA-associated ribosome binding site (5'-AGGAGG-3'; position 164 to 169) located within IR2) (Fig. 1a). The sequence of the codons 2 to 5 of the 9-aa peptide (5'-GTGAAAGCAGTG-3'; position 121 to 132) demonstrated significant homology to the ribosome stall sequences previously identified in the regulatory regions of cat57 and cat86 from Bacillus spp. but also to those of staphylococcal cat genes (2, 4, 9, 10) (Fig. 1b). Stalling of a ribosome in the reading frame of the 9-aa peptide might prevent the formation of an mRNA secondary structure between IR1 and IR2 and thus allow translation of the fexA transcript by a second ribosome.
Comparisons of the
fexA nucleotide sequence using the National
Center for Biotechnology Information standard nucleotide BLAST
program (
http://www.ncbi.nlm.nih.gov/BLAST/) revealed no significant
homology to known sequences. The Tmpred program (
http://www.ch.embnet.org/software/TMPRED_form.html)
predicts that the FexA protein has 14 transmembrane helices.
This feature is seen in a wide variety of efflux proteins of
the major facilitator superfamily (
8), including a cluster of
efflux proteins from gram-positive bacteria which confer resistance
to antimicrobial agents such as tetracyclines and lincomycin.
The deduced FexA amino acid sequence reveals only minor homologies
to other proteins deposited in the databases. Closest similarities
of 28 or 29% amino acid sequence identity were observed between
FexA and a multidrug efflux protein from
Lactobacillus plantarum (accession no.
NP_84696.1) as well as a metal-tetracycline/H
+ antiporter from
Bacillus halodurans (NP_242832.1). Comparisons
of the amino acid sequences revealed no more than 19% amino
acid identity between FexA and known chloramphenicol or florfenicol/chloramphenicol
exporter proteins (Fig.
2). Thus, FexA represents a novel type
of florfenicol/chloramphenicol efflux system which is distinctly
different from those of the FloR subgroup and the CmlA subgroup,
both found in clinically important gram-negative bacteria, as
well as from the chloramphenicol exporters so far detected in
soil and environmental bacteria of the genera
Streptomyces,
Corynebacterium, and
Rhodococcus (Fig.
2).
The detection of the florfenicol-chloramphenicol resistance
gene
fexA in staphylococci is to the best of our knowledge the
first report of a gene coding for a florfenicol efflux protein
in staphylococci. The location of this gene on a plasmid and
the observation that it is functionally active even in
E. coli suggest a potential transfer of
fexA-mediated resistance between
members of different bacterial species and genera.

Nucleotide sequence accession number.
The sequence of the
fexA gene has been deposited with the EMBL
database under accession number
AJ549214.

ACKNOWLEDGMENTS
This study was supported by grants of the Deutsche Forschungsgemeinschaft
(SCHW 382/6-1 and SCHW 382/6-2).
We thank Stefan Hörmansdorfer for providing S. lentus isolate 8 and Vera Nöding for excellent technical assistance.

FOOTNOTES
* Corresponding author. Mailing address: Institut für Tierzucht, Bundesforschungsanstalt für Landwirtschaft, Höltystr. 10, 31535 Neustadt-Mariensee, Germany. Phone: 49-5034-871242. Fax: 49-5034-871246. E-mail:
stefan.schwarz{at}fal.de.


REFERENCES
1 - Green, C. J., G. C. Stewart, M. A. Hillis, B. S. Vold, and K. F. Bott. 1985. Nucleotide sequence of the Bacillus subtilis ribosomal RNA operon rrnB. Gene 37:261-266.[CrossRef][Medline]
2 - Horinouchi, S., and B. Weisblum. 1982. Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J. Bacteriol. 150:815-825.[Abstract/Free Full Text]
3 - Kuroda, M., T. Ohta, I. Uchiyama, T. Baba, H. Yuzawa, I. Kobayashi, L. Cui, A. Oguchi, K. Aoki, Y. Nagai, J. Lian, T. Ito, M. Kanamori, H. Matsumaru, A. Maruyama, H. Murakami, A. Hosoyama, Y. Mizutani-Ui, N. K. Takahashi, T. Sawano, R. Inoue, C. Kaito, K. Sekimizu, H. Hirakawa, S. Kuhara, S. Goto, J. Yabuzaki, M. Kanehisa, A. Yamashita, K. Oshima, K. Furuya, C. Yoshino, T. Shiba, M. Hattori, N. Ogasawara, H. Hayashi, and K. Hiramatsu. 2001. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.[CrossRef][Medline]
4 - Lovett, P. S. 1990. Translational attenuation as the regulator of inducible cat genes. J. Bacteriol. 172:1-6.[Free Full Text]
5 - Lyon, B. R., and R. Skurray. 1987. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol. Rev. 51:88-134.[Free Full Text]
6 - Murray, I. A., and W. V. Shaw. 1997. O-Acetyltransferases for chloramphenicol and other natural products. Antimicrob. Agents Chemother. 41:1-6.[Medline]
7 - National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard. NCCLS document M31-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8 - Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:575-608.[Abstract/Free Full Text]
9 - Projan, S. J., J. Kornblum, S. L. Moghazeh, I. Edelman, M. L. Gennaro, and R. P. Novick. 1985. Comparative sequence and functional analysis of pT181 and pC221, cognate plasmid replicons from Staphylococcus aureus. Mol. Gen. Genet. 199:452-464.[CrossRef][Medline]
10 - Schwarz, S., and M. Cardoso. 1991. Nucleotide sequence and phylogeny of a chloramphenicol acetyltransferase encoded by the plasmid pSCS7 from Staphylococcus aureus. Antimicrob. Agents Chemother. 35:1551-1556.[Abstract/Free Full Text]
11 - Schwarz, S., and E. Chaslus-Dancla. 2001. Use of antimicrobials in veterinary medicine and mechanisms of resistance. Vet. Res. 32:201-225.[CrossRef][Medline]
12 - Schwarz, S., C. Kehrenberg, and K. K. Ojo. 2002. Staphylococcus sciuri gene, erm(33), encoding inducible resistance to macrolides, lincosamides, and streptogramin B antibiotics is a product of recombination between erm(C) and erm(A). Antimicrob. Agents Chemother. 46:3621-3623.[Abstract/Free Full Text]
13 - Schwarz, S., C. Werckenthin, and C. Kehrenberg. 2000. Identification of a plasmid-borne chloramphenicol-florfenicol resistance gene in Staphylococcus sciuri. Antimicrob. Agents Chemother. 44:2530-2533.[Abstract/Free Full Text]
14 - Stokes, H. W., and R. M. Hall. 1991. Sequence analysis of the inducible chloramphenicol resistance determinant in the Tn1696 integron suggests regulation by translational attenuation. Plasmid 26:10-19.[CrossRef][Medline]
15 - Tinoco, I., P. Borer, B. Dengler, M. Levine, O. Uhlenbeck, D. Crothers, and J. Gralla. 1973. Improved estimation of secondary structure in ribonucleic acid. Nat. New Biol. 246:171-172.
16 - Werckenthin, C., M. Cardoso, J.-L. Martel, and S. Schwarz. 2001. Antimicrobial resistance in staphylococci from animals with particular reference to bovine Staphylococcus aureus, porcine Staphylococcus hyicus and canine Staphylococcus intermedius. Vet. Res. 32:341-362.[CrossRef][Medline]
Antimicrobial Agents and Chemotherapy, February 2004, p. 615-618, Vol. 48, No. 2
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.2.615-618.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Kehrenberg, C., Aarestrup, F. M., Schwarz, S.
(2007). IS21-558 Insertion Sequences Are Involved in the Mobility of the Multiresistance Gene cfr. Antimicrob. Agents Chemother.
51: 483-487
[Abstract]
[Full Text]
-
Kadlec, K., Kehrenberg, C., Schwarz, S.
(2007). Efflux-mediated resistance to florfenicol and/or chloramphenicol in Bordetella bronchiseptica: identification of a novel chloramphenicol exporter. J Antimicrob Chemother
59: 191-196
[Abstract]
[Full Text]
-
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., Vester, B.
(2006). The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics.. Antimicrob. Agents Chemother.
50: 2500-2505
[Abstract]
[Full Text]
-
Kehrenberg, C., Schwarz, S.
(2006). Distribution of Florfenicol Resistance Genes fexA and cfr among Chloramphenicol-Resistant Staphylococcus Isolates.. Antimicrob. Agents Chemother.
50: 1156-1163
[Abstract]
[Full Text]
-
Poole, K.
(2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother
56: 20-51
[Abstract]
[Full Text]
-
Doublet, B., Schwarz, S., Kehrenberg, C., Cloeckaert, A.
(2005). Florfenicol Resistance Gene floR Is Part of a Novel Transposon. Antimicrob. Agents Chemother.
49: 2106-2108
[Abstract]
[Full Text]
-
Kehrenberg, C., Schwarz, S.
(2005). Florfenicol-Chloramphenicol Exporter Gene fexA Is Part of the Novel Transposon Tn558. Antimicrob. Agents Chemother.
49: 813-815
[Abstract]
[Full Text]
-
Kehrenberg, C., Ojo, K. K., Schwarz, S.
(2004). Nucleotide sequence and organization of the multiresistance plasmid pSCFS1 from Staphylococcus sciuri. J Antimicrob Chemother
54: 936-939
[Abstract]
[Full Text]